-
Product Insights
NewClaudin 18 – Drugs In Development, 2024
The Claudin 18 pipeline drugs market research report outlays comprehensive information on the Claudin 18 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Undisclosed which include indications of Gastric Cancer, Solid Tumor, and Unspecified. It also reviews key players involved in Claudin 18 targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewNS5B – Drugs In Development, 2024
The NS5B pipeline drugs market research report outlays comprehensive information on the NS5B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Hepatitis C, and Coronavirus Disease 2019 (COVID-19). It also reviews key players involved in NS5B targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewPhenylalanine 4 Hydroxylase – Drugs In Development, 2024
The Phenylalanine 4 Hydroxylase pipeline drugs market research report outlays comprehensive information on the Phenylalanine 4 Hydroxylase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Phenylketonuria (PKU). It also reviews key players involved in Phenylalanine 4 Hydroxylase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...
-
Product Insights
NewFrataxin Mitochondrial – Drugs In Development, 2024
The Frataxin Mitochondrial pipeline drugs market research report outlays comprehensive information on the Frataxin Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Friedreich Ataxia, and Cardiomyopathy. It also reviews key players involved in Frataxin Mitochondrial targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewGlypican 3 – Drugs In Development, 2024
The Glypican 3 pipeline drugs market research report outlays comprehensive information on the Glypican 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Hepatocellular Carcinoma, and Solid Tumor. It also reviews key players involved in Glypican 3 targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewCholinesterase – Drugs In Development, 2024
The Cholinesterase pipeline drugs market research report outlays comprehensive information on the Cholinesterase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Alzheimer's Disease, Dementia, and Ischemic Stroke. It also reviews key players involved in Cholinesterase targeted therapeutics development with respective active and dormant or discontinued projects. Note: *...
-
Product Insights
NewExodeoxyribonuclease III – Drugs In Development, 2024
The Exodeoxyribonuclease III pipeline drugs market research report outlays comprehensive information on the Exodeoxyribonuclease III targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in Exodeoxyribonuclease III targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Company Insights
NewMatter Diagnostics Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Matter Diagnostics Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Matter Diagnostics is a healthcare company that provides clinical needs for oncology, neurology, cardiology and infectious diseases. The company is headquartered in the US. GlobalData's Medical Devices company profile report, “Matter Diagnostics Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related...
-
Company Insights
NewNeoolife Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Neoolife Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Neoolife Inc is a medical equipment manufacturing company engaged in designing, production, marketing of tissue-engineered biomimetic heart valves and cardiovascular patches. The company is headquartered in Pittsburgh, Pennsylvania, the US. GlobalData's Medical Devices company profile report, “Neoolife Inc Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report...
-
Company Insights
NewInLine-Med GmbH Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our InLine-Med GmbH Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. InLine-Med GmbH is a Medical Equipment company that maufactures quality biopsy needles for cancer diagnosis and treatment. The Company is Headquartered in Magdeburg, Germany. GlobalData's Medical Devices company profile report, “InLine-Med GmbH Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related...